GlassScriptPhysician profile
Jeffrey B Neustadt
NPI 1366430407
$7,094.95
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,946 · 2020: $1,292 · 2021: $300 · 2022: $1,025 · 2023: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $280 · Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $280.11 |
| Food and Beverage | $252.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $6,141.69 | 2019-2023 | Zodiac, Invictus Mis |
| Stryker Corporation | $425.70 | 2019-2022 | |
| Kuros Biosciences USA, INC | $214.08 | 2019 | |
| Nuvasive, INC. | $148.33 | 2019 | |
| Depuy Synthes Sales INC. | $108.15 | 2019-2023 | Expedium Verse |
| Medtronic, INC. | $24.86 | 2021 | |
| Medtronic USA, INC. | $17.15 | 2020 | |
| Ethicon US, LLC | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Neustadt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.